KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Neogenomics (NEO) over the last 16 years, with Dec 2024 value amounting to $128.4 million.

  • Neogenomics' Shares Outstanding (Weighted Average) rose 0.80% to $129.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.2 million, marking a year-over-year increase of 0.80%. This contributed to the annual value of $128.4 million for FY2024, which is 0.70% up from last year.
  • Latest data reveals that Neogenomics reported Shares Outstanding (Weighted Average) of $128.4 million as of FY2024, which was up 0.70% from $127.5 million recorded in FY2023.
  • In the past 5 years, Neogenomics' Shares Outstanding (Weighted Average) ranged from a high of $128.4 million in FY2024 and a low of $111.0 million during FY2020.
  • For the 3-year period, Neogenomics' Shares Outstanding (Weighted Average) averaged around $127.4 million, with its median value being $127.5 million (2023).
  • Data for Neogenomics' Shares Outstanding (Weighted Average) shows a peak YoY rose of 10.89% (in 2021) over the last 5 years.
  • Neogenomics' Shares Outstanding (Weighted Average) (Yearly) stood at $111.0 million in 2020, then climbed by 10.89% to $123.1 million in 2021, then increased by 2.58% to $126.3 million in 2022, then rose by 0.92% to $127.5 million in 2023, then increased by 0.70% to $128.4 million in 2024.